No abstract available
Keywords:
Cirrhosis; Fibrosis; High-risk population; NASH; Screening.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Cost-Benefit Analysis
-
Diabetes Mellitus, Type 2 / diagnosis
-
Diabetes Mellitus, Type 2 / economics*
-
Diabetes Mellitus, Type 2 / epidemiology
-
Diabetes Mellitus, Type 2 / therapy
-
Diagnostic Screening Programs / economics*
-
Health Care Costs*
-
Healthy Lifestyle
-
Humans
-
Liver Cirrhosis / diagnosis
-
Liver Cirrhosis / economics
-
Liver Cirrhosis / epidemiology
-
Markov Chains
-
Models, Economic
-
Non-alcoholic Fatty Liver Disease / diagnosis*
-
Non-alcoholic Fatty Liver Disease / economics*
-
Non-alcoholic Fatty Liver Disease / epidemiology
-
Non-alcoholic Fatty Liver Disease / therapy
-
Predictive Value of Tests
-
Quality of Life
-
Quality-Adjusted Life Years
-
Reproducibility of Results
-
Risk Factors
-
Risk Reduction Behavior
-
Treatment Outcome
-
United States / epidemiology